BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9767158)

  • 1. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
    Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
    Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
    Gouardères C; Sutak M; Zajac JM; Jhamandas K
    Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
    Dupouy V; Zajac JM
    Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
    Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM
    Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF.
    Francés B; Lahlou H; Zajac JM
    Regul Pept; 2001 Apr; 98(1-2):13-8. PubMed ID: 11179773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
    Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
    Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice.
    Gelot A; Francés B; Gicquel S; Zajac JM
    Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
    Dupouy V; Zajac JM
    Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide FF, pain and analgesia.
    Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain.
    Desprat C; Zajac JM
    Brain Res Dev Brain Res; 1994 Oct; 82(1-2):118-26. PubMed ID: 7842499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual localization of neuropeptide FF receptors in the rat dorsal horn.
    Gouardères C; Roumy M; Advokat C; Jhamandas K; Zajac JM
    Synapse; 2000 Jan; 35(1):45-52. PubMed ID: 10579807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF.
    Kontinen VK; Kalso EA
    Peptides; 1995; 16(5):973-7. PubMed ID: 7479344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothermic effects of neuropeptide FF analogues in mice.
    Desprat C; Zajac JM
    Pharmacol Biochem Behav; 1997 Oct; 58(2):559-63. PubMed ID: 9300619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
    Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
    Courteix C; Coudoré-Civiale MA; Privat AM; Zajac JM; Eschalier A; Fialip J
    Br J Pharmacol; 1999 Jul; 127(6):1454-62. PubMed ID: 10455296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
    Fang Q; Jiang TN; Li N; Han ZL; Wang R
    Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats.
    Gelot A; Fioramonti J; Zajac JM; Bueno L
    Neuropeptides; 1995 Nov; 29(5):245-50. PubMed ID: 8587659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study.
    Quelven I; Roussin A; Zajac JM
    Neuroscience; 2004; 126(2):441-9. PubMed ID: 15207362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
    Quelven I; Roussin A; Zajac JM
    Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.